Search Results | Showing 41 - 50 of 111 results for "Pharmaceuticals" |
| | | ... was down 26 points at 5,344. Locally, no major economic news is expected on Thursday. In equities news, Sigma Pharmaceuticals is expected to post full year results while Washington H Soul Pattinson and Brickworks are slated to release first half results. ... |
| | | | ... world class companies in sectors that are under-represented on the Australian share market, such as technology, pharmaceuticals, food and beverage, consumer brands, aerospace and luxury goods," he continued. "Many of those companies are wired to the ... |
| | | | ... gained six cents to $74.20 and Westpac lost three cents to $32.45. Macquarie Group gained 67 cents to $49.22. Sigma Pharmaceuticals added $1.25, or 1.97 per cent, to $64.75 despite its half year profit falling by 38 per cent to $16.3 million. US stocks ... |
| | | | ... gained six cents to $74.20 and Westpac lost three cents to $32.45. Macquarie Group gained 67 cents to $49.22. Sigma Pharmaceuticals added $1.25, or 1.97 per cent, to $64.75 despite its half year profit falling by 38 per cent to $16.3 million. US stocks ... |
| | | | ... (ABS) releases labour force data for August. In equities news, Myer Holdings posts full year results and Sigma Pharmaceuticals first half results. Meanwhile, Caltex Australia chief executive Julian Segal is scheduled to speak at an American Chamber of ... |
| | | | ... news of soaring Spanish unemployment and surprising British growth figures, while earnings updates from major pharmaceuticals were also in focus. Indices had enjoyed large gains during the previous two days on growing expectations of an interest rate ... |
| | | | ... Institute of Builders dinner in Sydney. In company news, Myer releases its first half financial results and Sigma Pharmaceuticals releases its full year results. Foxtel chief executive Richard Freudenstein is due to speak at the ASTRA 2013 Conference ... |
| | | | ... down, companies that are concentrating on high-quality products that already have a strong domestic market, like pharmaceuticals, still have a lot of potential to be squeezed. Smaller companies are also being encouraged to bring their operations into ... |
| | | | ... cars. Stimulus programs have also seen a property recovery, as well as increased spending on consumer goods and pharmaceuticals, after the government confirmed that it would continue with a scheme that subsidises medicine, similar to Australia's, said ... |
| | | | ... companies contracted to supply Medicare (for the elderly) and Medicaid (for the poor) adversely affected. While pharmaceuticals would be negatively impacted due to less medically insured people, private health companies would likely benefit as taxes ... |
|
